Dow Down 0.92% Nasdaq Down 0.83%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqGM
0.46 Down 0.01(3.08%) Oct 22, 4:00PM EDT
|After Hours : 0.68 Up 0.22 (47.09%) Oct 22, 7:59PM EDT
Prev Close:0.48
Open:0.47
Bid:0.60 x 1000
Ask:N/A
1y Target Est:5.13
Beta:2.5
Next Earnings Date:N/A
Day's Range:0.46 - 0.49
52wk Range:0.46 - 3.93
Volume:1,114,945
Avg Vol (3m):602,294
Market Cap:36.77M
P/E (ttm):N/A
EPS (ttm):-0.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTX

Comparison

Symbol% ChgMkt Cap
CYTXDown 3.08%36.77M
ASTMUp 1.37%23.68M
BAXDown 0.41%37.03B
OSIRDown 1.15%441.21M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.27
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.40
Quarterly EPS Est (Sep-14) :-0.07
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a cell therapy company, develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback